首页> 外文期刊>Cancer Medicine >Associations of multimorbidity and patient‐reported experiences of care with conservative management among elderly patients with localized prostate cancer
【24h】

Associations of multimorbidity and patient‐reported experiences of care with conservative management among elderly patients with localized prostate cancer

机译:局部前列腺癌的老年患者保守管理的多重药和患者报告的关心经验的关键词

获取原文
           

摘要

Background Many elderly?localized prostate cancer?patients could benefit from conservative management (CM). This retrospective cohort study examined the associations of patient‐reported access to care and multimorbidity on CM use patterns among Medicare Fee‐for‐Service (FFS) beneficiaries with localized prostate cancer. Methods We used linked Surveillance, Epidemiology, and End Results cancer Registry, Medicare Claims, and the Medicare Consumer Assessment of Healthcare Providers and Systems (MCAHPS) survey files. We identified FFS Medicare Beneficiaries (age?≥ 66; continuous enrollment in Parts?A?& B) with?incident?localized prostate cancer?from?2003 to 2013?and?a completed MCAHPS survey measuring patient‐reported experiences of care within 24?months after diagnosis (n?=?496). We used multivariable models to examine MCAHPS measures (getting needed care, timeliness of care, and doctor communication) and multimorbidity on CM use. Results Localized prostate cancer?patients with multimorbidity were less likely to use CM (adjusted odds ratio (AOR)=0.42 (0.27‐ 0.66), P??.001); those with higher scores on timeliness of care (AOR?=?1.21 (1.09, 1.35), P??.001), higher education attainment (3.21?=?AOR (1.50,6.89), P?=?.003), and impaired mental health status (4.32?=?AOR (1.86, 10.1) P??.001) were more likely to use CM. Conclusion(s) Patient‐reported experience with timely care was significantly and positively associated with CM use. Multimorbidity was significantly and inversely associated with CM use. Addressing specific modifiable barriers to timely care along the cancer continuum for elderly localized prostate cancer patients with limited life expectancy could reduce the adverse effects of overtreatment on health outcomes and costs.
机译:背景许多老年人?局部前列腺癌?患者可以从保守管理(cm)中受益。该回顾性队列研究审查了患者报告的患者的护理和多重药物在CM使用模式中的关心和多重药物的关联,与局部前列腺癌的医疗保险服务费用(FFS)受益人。方法采用链接监测,流行病学和最终结果癌症登记处,医疗保险索赔和医疗保健提供者和系统(MCAHPS)调查文件的医疗保险消费者评估。我们确定了FFS Medicare受益人(年龄?≥66;零件持续注册?A?&B)?局部前列腺癌?来自?2003年至2013年?和?一个完成的McAhps调查测量患者报告的患者报告的患者报告的护理经历?诊断后的月份(n?= 496)。我们使用了多变量的型号来检查McAhps措施(越来越需要护理,守恒,以及CM CM使用的多元化性。结果局部前列腺癌?多药率的患者不太可能使用Cm(调节的差距(AOR)= 0.42(0.27-0.66),p?<001);那些在护理时期得分更高的人(AOR?=?1.21(1.09,1.35),P?<?001),高等教育达成(3.21?=?AOR(1.50,6.89),P?= 003)和心理健康状况受损(4.32?=?AOR(1.86,10.1)p?<?001)更可能使用cm。结论患者报告的及时护理经验显着且与CM使用呈正相关。多重无水性显着并与CM使用反向相关。解决特定的可修改的障碍,以沿着癌症连续性的癌症患者为预期寿命有限的癌症患者,可以降低过度处理对健康结果和成本的不利影响。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号